Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection: Results of EORTC Translational Research Fund studies

European Journal of Cancer

Volumn 40, Issue 4, 2004, Pages 503-507

  Oliver, R J ^a   Woodwards, R T M ^b   Sloan, P ^a   Thakker, N S ^a   Stratford, I J ^c   Airley, R E ^d  

^a UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Cell hypoxia; Glucose transport protein; Glut 1 protein; Hypoxia; Mouth neoplasms; Oral cancer; Prognosis

Indexed keywords

GLUCOSE TRANSPORTER 1;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1242316333     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.10.024     Document Type: Article

References (27)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer. 80:1999;827-841.
2. Hindle I., Downer M.C., Speight P.M. The epidemiology of oral cancer. Br. J. Oral Maxillofac. Surg. 34:1996;471-476.
3. Robinson K.L., Macfarlane G.J. Oropharyngeal cancer incidence and mortality in Scotland. are rate still increasing? Oral Oncol. 39:2003;31-36.
4. Haddadin K.J., Soutar D.S., Webster M.H.C., Robertson A.G., Oliver R.J., MacDonald D.G. Natural history and patterns of recurrence of tongue tumours. Br. J. Plast. Surg. 53:2000;279-285.
5. Worburg O. The Metabolism of Tumours. 1930;Constable, London.
6. Minn H., Lapela M., Klemi P.J.et al. Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer. J. Nucl. Med. 38:1997;1907-1911.
7. Nakasone Y., Inoue T., Oriuchi N.et al. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. Ann. Nucl. Med. 15:2001;505-512.
8. Kawamura T., Kusakabe T., Sugino T.et al. Expression of glucose transporter-1 in human gastric carcinoma - association with tumor aggressiveness, metastasis, and patient survival. Cancer. 92:2001;634-641.
9. Rege S., Safa A.A., Chaiken L., Hoh C., Juillard G., Withers H.R. Positron emission tomography. an independent indicator of radiocurability in head and neck carcinomas Am. J. Clin. Oncol. 23:2000;164-169.
10. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41:1996;31-39.
11. Nordsmark M., Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother. Oncol. 57:2000;39-43.
12. Koukourakis M.I., Giatromanolaki A., Sivridis E.et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;1192-1202.
13. Behrooz A., Ismail-Beigi F. Stimulation of glucose transport by hypoxia. signals and mechanisms News Physiol. Sci. 14:1999;105-110.
14. Brizel D.M., Dodge R.K., Clough R.W., Dewhirst M.W. Oxygenation of head and neck cancer. changes during radiotherpy and impact on treatment outcome Radiother. Oncol. 53:1999;113-117.
15. Nordsmark M., Overgaard M., Overgaard J. Testing the hypothesis. pretreatment oxygenation predicts radiation response in advanced head & neck squamous cell carcinoma Eur. J. Cancer. 35:1999;609.
16. Airley R., Loncaster J., Davidson S.et al. Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin. Cancer Res. 7:2001;928-934.
17. Loncaster J.A., Harris A.L., Davidson S.E.et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia. correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res. 61:2001;6394-6399.
18. Koukourakis M.I., Giatromanolaki A., Sivridis E.et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin. Cancer Res. 7:2001;3399-3403.
19. Baer S., Casaubon L., Schwartz M.R., Marcogliese A., Younes M. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope. 112:2002;393-396.
20. Reisser C., Eichhorn K., Herold-Mende C., Born A.I., Bannasch P. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int. J. Cancer. 80:1999;194-198.
21. Kunkel M., Reichert T.E., Benz P.et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 97:2003;1015-1024.
22. Kato H., Takita J., Miyazaki T.et al. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Anticancer Res. 22:2002;2635-2639.
23. Brizel D.M., Schroeder T., Scher R.L.et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51:2001;349-353.
24. Bernier J., Denekamp J., Rojas A.et al. ARCON. accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC) Radiother. Oncol. 55:2000;111-119.
25. Kaanders J.H.A.M., Bussink J., van der Kogel A.J. ARCON. a novel biology-based approach in radiotherapy Lancet Oncol. 3:2002;728-737.
26. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
27. Noguchi Y., Saito A., Miyagi Y.et al. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth. Cancer Lett. 154:2000;175-182.